Evidence map›Paper›PMID 23002097›Full record

ArticleAmerican journal of respiratory cell and molecular biology2013

Regulatory T cells reduce acute lung injury fibroproliferation by decreasing fibrocyte recruitment.

Brian T Garibaldi, Franco R D'Alessio, Jason R Mock, D Clark Files, Eric Chau, Yoshiki Eto, M Bradley Drummond, Neil R Aggarwal, Venkataramana Sidhaye, Landon S King

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04482621 (Decitabine for COVID-19 Pneumonia-ARDS Treatment), which is not on this map. Cited by 114 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed, 1 pooled it
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04482621 phase2suspendednot on this mapstarted 2020, after this paper: background citation

Decitabine for COVID-19 Pneumonia-ARDS Treatment: DART Trial

TypeinterventionalSponsorJohns Hopkins UniversityRan2020 to 2026Enrolled33ConditionsCOVID-19ArmsDecitabine, Placebo Saline
3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 1 synthesis or guideline pooled it, 179 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction.American journal of respiratory and critical care medicine · 2014
    Trial
  4. Multi-omics reveals a novel Cxcr4Clinical and translational medicine · 2026
    Article
  5. Elevated ST2Arthritis research & therapy · 2026
    Article
  6. CNS1-dependent regulatory T cells shape recovery from acute lung injury.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Article
  7. Article
  8. Article
  9. Single-Cell Insights Into Macrophage Subtypes in Pulmonary Infections.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  10. Review
  11. Article
  12. Article
  13. T Regulatory Mechanisms in Airway and Interstitial Lung Disease.Seminars in respiratory and critical care medicine · 2025
    Review
  14. Article
  15. Identifying TNFSF4Stem cell research & therapy · 2025
    Article
  16. Review
  17. Review
  18. Review
  19. Macrophages and Pulmonary Fibrosis.Current molecular medicine · 2025
    Review
  20. Gut-derived immune cells and the gut-lung axis in ARDS.Critical care (London, England) · 2024
    Review

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Brian T GaribaldiDivision of Pulmonary and Critical Care Medicine, Johns Hopkins Asthma and Allergy Center, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA. bgariba1@jhmi.edu
Franco R D'Alessio
Jason R Mock
D Clark Files
Eric Chau
Yoshiki Eto
M Bradley Drummond
Neil R Aggarwal
Venkataramana Sidhaye
Landon S King
Johns Hopkins University · US

Funding

Phenotype-Specific Immune Responses in the Systemic VasculitidesP30AR053503 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI CASCIOLA-ROSEN, LIVIA A · 2006 to 2015
$6.4M
Determinants of Resolution in Acute Lung InjuryR01HL089346 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI KING, LANDON S · 2008 to 2012
$2.0M
Effects of shear stress on regulation of epithelial permeabilityK08HL085763 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI SIDHAYE, VENKATARAMANA K · 2008 to 2012
$678k
Mechanisms of COPD Subphenotype DevelopmentK23HL103192 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI DRUMMOND, MICHAEL BRADLEY · 2010 to 2013
$650k
Resolution and repair of acute lung injury by macrophage-derived iNOSK99HL103973 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI D'ALESSIO, FRANCO RAFAEL · 2010 to 2011
$273k
Regulatory Tcells and the fibroproliferative response in Acute Lung InjuryF32HL104908 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI GARIBALDI, BRIAN · 2010 to 2011
$109k
Regulatory T Cell Modulation of the Alveolar Epithelium in Acute Lung InjuryF32HL110561 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI MOCK, JASON ROBERT · 2012 to 2012
$51k
NHLBI NIH HHS F32 HL104908NHLBI NIH HHS F32 HL110561NHLBI NIH HHS K99 HL103973NHLBI NIH HHS R01 HL089346
6 · The paper itself

Abstract

Acute lung injury (ALI) causes significant morbidity and mortality. Fibroproliferation in ALI results in worse outcomes, but the mechanisms governing fibroproliferation remain poorly understood. Regulatory T cells (Tregs) are important in lung injury resolution. Their role in fibroproliferation is unknown. We sought to identify the role of Tregs in ALI fibroproliferation, using a murine model of lung injury. Wild-type (WT) and lymphocyte-deficient Rag-1(-/-) mice received intratracheal LPS. Fibroproliferation was characterized by histology and the measurement of lung collagen. Lung fibrocytes were measured by flow cytometry. To dissect the role of Tregs in fibroproliferation, Rag-1(-/-) mice received CD4(+)CD25(+) (Tregs) or CD4(+)CD25(-) Tcells (non-Tregs) at the time of LPS injury. To define the role of the chemokine (C-X-C motif) ligand 12 (CXCL12)-CXCR4 pathway in ALI fibroproliferation, Rag-1(-/-) mice were treated with the CXCR4 antagonist AMD3100 to block fibrocyte recruitment. WT and Rag-1(-/-) mice demonstrated significant collagen deposition on Day 3 after LPS. WT mice exhibited the clearance of collagen, but Rag-1(-/-) mice developed persistent fibrosis. This fibrosis was mediated by the sustained epithelial expression of CXCL12 (or stromal cell-derived factor 1 [SDF-1]) that led to increased fibrocyte recruitment. The adoptive transfer of Tregs resolved fibroproliferation by decreasing CXCL12 expression and subsequent fibrocyte recruitment. Blockade of the CXCL12-CXCR4 axis with AMD3100 also decreased lung fibrocytes and fibroproliferation. These results indicate a central role for Tregs in the resolution of ALI fibroproliferation by reducing fibrocyte recruitment along the CXCL12-CXCR4 axis. A dissection of the role of Tregs in ALI fibroproliferation may inform the design of new therapeutic tools for patients with ALI.

Indexed as

Acute Lung InjuryAdoptive TransferAnimalsBenzylaminesCell ProliferationChemokine CXCL12CyclamsFibroblastsHeterocyclic CompoundsHomeodomain ProteinsLipopolysaccharidesMiceMice, Inbred C57BLMice, KnockoutMyofibroblastsReceptors, CXCR4BenzylaminesChemokine CXCL12Cxcl12 protein, mouseCXCR4 protein, mouseCyclamsHeterocyclic CompoundsHomeodomain ProteinsLipopolysaccharidesplerixaforRAG-1 proteinReceptors, CXCR4

Identifiers

PMID23002097
PMCPMC3547087
OpenAlexW2151856750

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.